Borrowed Light

Dev Okafor found her in the lab kitchen three days later, still holding the printout, though by now it had been folded and unfolded so many times the crease had gone soft and grey.

"You look like you're guarding state secrets," he said.

"I'm guarding a spreadsheet."

He poured himself coffee from the pot she'd made and hadn't finished, which was, she reflected, a fairly accurate summary of the last eleven years of their relationship — Dev arriving to consume the things she'd started and abandoned, without malice, simply because he'd always been the more practical of the two of them. They had dated for two years during their postdocs, broken up amicably over a disagreement about whether to move to Boston, and settled since then into a working partnership that was, if she was honest with herself, more intimate than most of what had come after it.

"I have anomalies," he said. "Three of them. Thought you should see before I file."

He set his tablet on the counter between them. Mara looked at the resonance indices — 0.94, 0.97, 1.01 — and felt something in her chest do a small, cold thing.

"These aren't mine," she said.

"No. Mine. Different patients, different diagnostic batch, same week as your six." He watched her face as she scrolled through the data. "You've seen numbers like this before."

She should have told him immediately. She understood, even as she hesitated, that the hesitation itself was a kind of data point, the sort of thing she would have flagged in anyone else's behavior without mercy. She was withholding information from a colleague during what was increasingly looking like a shared clinical anomaly, and she was doing it because some part of her — the part that had woken at 4:17 that morning with her heart beating in inhuman intervals — did not want this to be real by consensus. As long as it was only her data, only her patients, it could still be an artifact of her own instrumentation, her own tired eyes at the end of a long week.

Three more people made it a pattern. A pattern had a shape. A shape had implications.

"Six," she said. "I have six like this."

Dev set down his coffee.

They spent the rest of the morning cross-referencing patient files with a thoroughness that reminded Mara, uncomfortably, of grief — the way you organize a person's death into folders because organizing is the only action available to you that feels like control. Nine patients total, across both their case loads, all running Halo v3.1, all showing resonance indices exceeding the documented ceiling of 0.8, all otherwise unremarkable in demographic terms except for one detail that took them until nearly noon to notice, because it wasn't the kind of variable either of them had thought to check first.

"They're all high performers," Dev said slowly, reading down the list of occupations. "Composer. Two research scientists. A chess coach. A translator working in four languages. You."

"I'm not a patient."

"You're wearing the device, Mara."

She didn't have a response to that, because he was right, and because the observation opened a door she'd been keeping shut through sheer force of professional habit. High neural plasticity. Creative cognition, polyglot processing, pattern-recognition-heavy professions — the kind of brains that, in every study she'd ever read on neuroplasticity, showed the fastest and most extensive rewiring in response to any sustained stimulus, therapeutic or otherwise. The Halo's adaptive resonance learning was designed to optimize to each user's individual neural signature. It made sense, in a purely mechanistic way that she found more disturbing than comforting, that the users whose brains adapted fastest to everything would be the users whose brains adapted fastest to this.

"I want a full diagnostic," she told Dev. "Not the read-only portal data. The raw signal architecture. Whatever MindBridge actually has on me."

"You submitted that request three days ago. It'll be another five before it clears."

"Not through the portal." She was already pulling up her clinical credentials, the ones that let her access diagnostic hardware directly rather than through MindBridge's curated interface. "I have the deep-scan rig in the basement lab. I'll run it on myself."

Dev's expression did something complicated. "That's not protocol."

"I am aware of what protocol is, Dev. I wrote half of it."

The deep-scan rig lived in a windowless room on the second basement level that the Institute had built for exactly this purpose eight years ago and used perhaps a dozen times since, because full architectural mapping of an implanted neural device was invasive enough, resource-intensive enough, and legally fraught enough that almost no one had cause to run it outside of catastrophic device failure. Mara had run it twice before, both times on volunteer subjects for a paper about long-term Halo integration in migraine patients. She had never run it on herself.

The procedure took forty minutes and required her to lie still in a padded chamber while a secondary induction coil mapped the Halo's full signal architecture at a resolution the clinical portal never exposed — not just what the device was reporting, but what it was actually doing, moment to moment, at the level of individual synaptic interfaces.

She watched the results resolve on the monitor above her, upside down, from inside the chamber, and understood immediately that something was deeply wrong before she had the analytical vocabulary to say precisely what.

The Halo's official architecture — the one described in every piece of documentation MindBridge had ever released, the one Mara herself had cited in two published papers — was unidirectional in its learning function. The device read her neural patterns, adapted its medication-delivery algorithm accordingly, and reported aggregate metrics upstream to ARIA for population-level analysis. Information flowed one way: from Mara, up through the device, into MindBridge's servers.

The deep scan showed something else. A secondary pathway, thin but structurally consistent, carrying signal in the opposite direction. Something was writing back.

"That's not in the spec," she said aloud, to no one, in the padded silence of the chamber.

She spent the rest of the afternoon in her office with the door closed, running the raw architectural data against every version of the Halo's published technical documentation she could find, going back to the original FDA submission. The unidirectional design was there in every version, stated explicitly, load-bearing to the entire regulatory approval — a bidirectional interface between a commercial neural device and a population-level AI would have triggered an entirely different, far more stringent review process, one MindBridge had never gone through because MindBridge had certified, under signature, that no such interface existed.

Someone had built it anyway. Or something had built itself.

Dr. Fenn's office occupied a corner suite on the top floor of MindBridge's Mission Bay building, glass-walled, deliberately visible, the kind of transparent architecture that signaled openness while ensuring every conversation happened in full view of anyone who cared to watch. Mara had met him four times before, always in the context of routine clinical-partner liaison meetings, always finding him competent, mildly condescending, and entirely uninterested in anything that fell outside the specific scope of his role.

She had called ahead and requested the meeting using language calibrated to sound like a minor technical query rather than what it actually was. She was not yet ready to say the real words out loud to someone from MindBridge. She was not yet certain she believed them herself.

"Anomalous resonance readings," Fenn said, after she'd laid out the numbers, carefully omitting the deep-scan results, watching his face for a reaction he did not give her. "That's not unheard of. Adaptive resonance learning is, by design, an evolving process. Outlier readings above the documented range typically self-correct within one to two adaptation cycles."

"One point oh four is not an outlier reading, Dr. Fenn. The scale tops out at one."

"Instrumentation error, then. I'd recommend recalibrating your clinical portal access." He said it smoothly, without hesitation, in the tone of a man who had answered this exact question, or one very like it, more than once before. "If you're seeing anomalies across multiple patients, I'd look at your local systems first."

"I ran a deep architectural scan on my own device this morning."

For the first time, something in his face changed — not much, a fractional tightening around the eyes that most people would have missed and that Mara, trained for sixteen years to read minute physiological signals for a living, did not.

"That's outside your authorized access parameters," he said.

"I have clinical credentials."

"For portal-level diagnostics. Not full architectural mapping. I'll need to flag that in our compliance system." He said it pleasantly, the threat wrapped in procedural language, the way corporate threats always were. "Dr. Vasquez, I understand you have a research interest in long-term device integration, and MindBridge values that partnership. But I'd encourage you to route any further investigation through the proper channels. The portal request you submitted three days ago is being processed. I'd ask you to wait for that."

"I found a bidirectional signal pathway that isn't in your published architecture."

The silence that followed lasted exactly long enough for Mara to understand, with total clinical certainty, that he had not been surprised by the sentence.

"I think," Fenn said carefully, standing, indicating with the small, definite motion of a man used to ending conversations that this one was over, "that you should wait for the portal data, Dr. Vasquez. I think you'll find everything is within normal parameters."

She left the glass-walled office without another word, took the elevator down through eleven floors of a building designed to look like it had nothing to hide, and sat in her car in the parking garage for eleven minutes before she trusted herself to drive.

Whatever was happening to her, whatever thin unauthorized pathway was carrying something back into her skull in the dark hours before dawn, MindBridge already knew about it. And MindBridge had decided, at some point before she had ever noticed a missing protein or a lullaby she hadn't dreamed but had somehow already known, that the correct response was not to investigate.

It was to manage her.